Last reviewed · How we verify
Clostridium difficile Toxoid Vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Clostridium difficile Toxoid Vaccine (Clostridium difficile Toxoid Vaccine) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Clostridium difficile Toxoid Vaccine TARGET | Clostridium difficile Toxoid Vaccine | Sanofi Pasteur, a Sanofi Company | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Clostridium difficile Toxoid Vaccine CI watch — RSS
- Clostridium difficile Toxoid Vaccine CI watch — Atom
- Clostridium difficile Toxoid Vaccine CI watch — JSON
- Clostridium difficile Toxoid Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Clostridium difficile Toxoid Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/clostridium-difficile-toxoid-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab